Using Visual Arrays to Support Understanding of Genetic Risk
Examining Genetic Literacy and Numeracy in the General Population
2 other identifiers
interventional
1,045
1 country
1
Brief Summary
The goal of this study is to understand how people understand risk from genetic testing. The investigators want to understand what visual aid best helps people accurately assess risk. The investigators also want to understand how people relate risk to their health. The main questions the study aims to answer are:
- 1.Which visual aid most accurately show genetic risk?
- 2.How do people perceive risk related to genetic test results?
- 3.What factors are associated with people discussing their results with family?
- 4.receive of of two visual aids showing risk
- 5.state their estimation of risk
- 6.answer questions about how they feel about risk and sharing information with family
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 22, 2025
CompletedFirst Posted
Study publicly available on registry
May 29, 2025
CompletedStudy Start
First participant enrolled
July 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 18, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 18, 2025
CompletedFebruary 18, 2026
September 1, 2025
21 days
April 22, 2025
February 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Risk Accuracy
closest approximation to risk percentage depicted in the visual array
immediately after the intervention
Secondary Outcomes (2)
Risk Perceptions
baseline
Communication Intent
immediately after the intervention
Study Arms (2)
Visual Array
EXPERIMENTALSingle, side-by-side visual array
Narrative Visual Array
EXPERIMENTALEvolving narrative showing sequential visual arrays
Interventions
Evolving narrative with sequential visual arrays
Eligibility Criteria
You may qualify if:
- ability to read and understand English
- opt-in consent
You may not qualify if:
- incorrect responses to validation questions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Boston College
Boston, Massachusetts, 02467, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew A Dwyer, PhD
Boston College
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Chief, Reproductive Endocrine Unit; Professor of Medicine, Harvard Medical School; Director, MGH Harvard Center for Reproductive Medicine
Study Record Dates
First Submitted
April 22, 2025
First Posted
May 29, 2025
Study Start
July 28, 2025
Primary Completion
August 18, 2025
Study Completion
August 18, 2025
Last Updated
February 18, 2026
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Start date: within one month of the publication of study results. End date: one year after posting.
- Access Criteria
- HarvardDataverse platform
Anonymized data will be shared via the HarvardDataverse platform.